Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma. Lin B, Ziebro J, Smithberger E, Skinner KR, et al. Neuro Oncol 2022 Nov 23:noac254. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin B, Ziebro J, Smithberger E, Skinner KR, et al. Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma. Neuro Oncol 2022 Nov 23:noac254. doi: 10.1093.
PMID: 36416495